What changed
Adjusted EPS of $0.97 came in below the $0.99 consensus, a 2.1% miss, though it rose 11% YoY from $0.87. Revenue printed $1,107M, up 4.6% YoY, with Q4 FY26 adjusted EPS guided to $1.10-$1.20 and FY2026 to $3.94-$4.04. Margins were pressured by higher healthcare costs, higher selling compensation, and increased advertising and marketing spend supporting preneed sales growth, partly offset by higher trust fund income and lower corporate G&A.
Why it matters
Adjusted EPS of $0.97 came in below the $0.99 consensus, a 2.1% miss, though it rose 11% YoY from $0.87. Revenue printed $1,107M, up 4.6% YoY, with Q4 FY26 adjusted EPS guided to $1.10-$1.20 and FY202